samedan logo
 
 
 
spacer
home > pmps > winter 2001 > lean compliance in manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Lean Compliance in Manufacturing

This article looks at what life science companies can do to ensure that compliance activities do not become a bottleneck when production constraints are removed.

Today's Context
The race to get more new drugs to market faster continues. This race is a team event and all areas of the business must be part of the team. Discover more; prove more; get more NDAs; create a larger market; get the product flowing reliably into the marketplace - and all faster than before.

The reorganisation of businesses, both in response to and in anticipation of change, presents the opportunity to create the right processes with the right performance. This is significant to all pharmaceutical processes, given the volume of data, the need for good information in the right place at the right time, and the imperative of data security. When a world-leading ethical pharmaceutical company looked at the output of one of its factories, alarm bells began to ring.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Bruce Ramsay, Supply Chain Director at World Class International
Bruce Ramsay is Supply Chain Director at World Class International, a US- and European-based consultancy, specialising in process design, web technology and managed services in the pharmaceutical and high technology industries.

spacer
Bruce Ramsay
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement